HIV Prevention Act Angers Ugandan AIDS Activists

Uganda’s president recently signed the HIV and AIDS Prevention and Control Act into law. The bill criminalizes the transmission of HIV and also enforces mandatory testing. Such provisions have upset activists who want to de-stigmatize Uganda’s HIV-positive community.

The country’s parliament passed the act in May. President Yoweri Museveni signed it act into law July 31.

Health advocates say they are alarmed by a number of passages in the bill that sanction forced disclosure, criminalize transmission and mandate testing for certain groups.

Asia Russell, the Director of International Policy with Global Access Project, explains why these passages are so troubling.

“This act, contrary to best practice, to human rights, to evidence of what works in contexts like Uganda, would actually criminalize HIV,” she said. “And what we’ve seen is that in contexts where knowing your HIV status can be used as a criminal liability against you, it actually makes people hesitate. And the last thing we need is one more reason for people at greatest risk of infection to hesitate before seeking a test.”

Uganda was originally a leader in working to reduce AIDS rates. After the disease arrived in the country in the 1980s, officials opened up the first voluntary HIV counseling and testing clinic in sub-Saharan Africa.

Media campaigns and the nationwide “ABC” program — promoting abstinence, being faithful and condom usage — helped bring down the HIV infection rate from 18 percent in 1991 to just under 6 percent in 2002.

Lizabeth Paulat
Voice of America
Read The Full Story

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below